Chemopreventative Celecoxib Fails to Prevent Schwannoma Formation or Sensorineural Hearing Loss in Genetically Engineered Murine Model of Neurofibromatosis Type 2

Oncotarget - United States
doi 10.18632/oncotarget.22002
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Exth-13. Reduction of Tumor Burden and Hearing Loss With a Multiple Receptor Tyrosine Kinase Inhibitor Brigatinib in a Genetically Engineered Mouse Model of Neurofibromatosis Type 2

Neuro-Oncology
Cancer ResearchOncologyNeurology
2018English

Sensorineural Hearing Loss

Otology and Neurotology
MedicineOtorhinolaryngologySensory SystemsNeurology
2013English

Sensorineural Hearing Loss

2007English

Sensorineural Hearing Loss

Journal of Clinical Rheumatology
MedicineRheumatology
2010English

Contralateral Sensorineural Hearing Loss (SNHL) After Vestibular Schwannoma Surgery: Report of 4 Cases

Journal of Otolaryngology-ENT Research
2017English

Acute Sensorineural Hearing Loss

Acta Oto-Laryngologica
MedicineOtorhinolaryngology
2017English

Sudden Sensorineural Hearing Loss

CMAJ
Medicine
2017English

Sudden Sensorineural Hearing Loss

2013English

Screening Patients With Sensorineural Hearing Loss for Vestibular Schwannoma Using a Bayesian Classifier

Skull Base
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy